PRAC starts review of safety of injectable iron-containing medicines September 8, 2026 PharmacovigilanceSafety Announcements 08 Sep 2026
Tavneos (avacopan): Direct communication to healthcare professionals 16 July 2026 Health professionalsMedicinesPharmacovigilance 16 Jul 2026
Highlights of the Pharmacovigilance Risk Assessment Committee (PRAC) meeting, 6 – 9 July 2026 15 July 2026 PharmacovigilanceSafety Announcements 15 Jul 2026
Highlights of the Pharmacovigilance Risk Assessment Committee (PRAC) meeting, 8 – 11 June 2026 June 18 2026 Safety AnnouncementsPharmacovigilance June 18, 2026
Ontozry (cenobamate): Direct communication to healthcare professionals 14 May 2026 PharmacovigilanceHealth professionalsAnnouncements 14 May 2026
Highlights of the Pharmacovigilance Risk Assessment Committee (PRAC) meeting, 7 – 10 April 2026 April 17 2026 Safety AnnouncementsPharmacovigilance 17 Apr 2026
Highlights of the Pharmacovigilance Risk Assessment Committee (PRAC) meeting, 27 – 30 October 2025 7 November 2025 PharmacovigilanceSafety Announcements 07 Nov 2025
Highlights of the Pharmacovigilance Risk Assessment Committee (PRAC) meeting, 1 – 4 September 2025 September 9, 2025 Safety AnnouncementsPharmacovigilance 09 Sep 2025
Rybelsus: Risk of medication error due to formulation change 6 August 2025 PharmacovigilanceSafety Announcements 06 Aug 2025
Highlights of the Pharmacovigilance Risk Assessment Committee (PRAC) meeting, 7 – 10 July 2025 15 July 2025 PharmacovigilanceSafety Announcements 15 Jul 2025
